🔗 Share this article

An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Drug Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these accounts privately for source information, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with numerous of members share “before and after” images, administration instructions and claims of rapid British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Professionals Voice Concerns

However, doctors and chemists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.

Several experts stated the demand for the experimental drug could be connected to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and consumer regulations, risking fines, prosecution or prison.

Platform Response and Content Removal

According to TikTok, the platform has taken down problematic content and banned related keywords and query recommendations. The organization said it was committed to maintaining the platform secure and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Research also found groups with up to 9,000 participants selling retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, filled with photos of slimming results, glowing reviews and step-by-step guides for preparing or administering at home.

Within minutes of entering one group, a vendor posted contact information, where most transactions occur. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, medical conditions or previous experience.

Product Details and Pricing

Inside these communities, posts display black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service stated it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they can’t verify. Even if the science behind this drug is sound, these online products may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has previously encountered individuals harmed by self-injection from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject patients to possibly serious health risks”.